Coupon Code: 43790 ENGLISH | 简体中文

Tourism News Share wonderful travel information

booking

The 1-Year Follow-up Results of LuX-Valve Plus were Officially Released at TCT 2024

2024/11/1 21:21:34

WASHINGTON, Nov. 1, 2024 /PRNewswire/ -- Jenscare Scientific Co., Ltd. ("Jenscare" or the "Company") (HKEX: 9877), an innovative medical device company dedicated to interventional treatment for structural heart diseases with TTVR breakthroughs, has just released the 1-year outcome of LuX-Valve Plus TRAVEL II study at 2024 Transcatheter Cardiovascular Therapeutics Conference (TCT 2024) by on October 29th in Washington, D.C., U.S..

TRAVEL II study aims to evaluate the long-term safety and efficacy of LuX-Valve Plus in the application on patients with severe tricuspid regurgitation (TR) and high surgical risk. The clinical trial enrolled 96 patients from 15 centers in China. The results showed that the device success rate was about 97%, and the average device operation time was around 35.56 minutes.

Safety results showed that the incidence of composite events remained low at 12.50%.

Efficacy results showed that TR grade, NYHA classification, and QoL improved significantly and continuously. At 1 year,

Professor Juan F. Granada concluded that LuX-Valve Plus system is a versatile TTVR device that does not depend on radial force for anchoring. Its innovative design (ventricular septal anchor & leaflet-grasping clips) provides optional mechanisms for anchoring and stability. The multicenter, TRAVEL II study showed that LuX-Valve Plus system is safe and effective in achieving short delivery times, low 1-year composite event rates, significant TR reduction and improvement in functional and QoL metrics at 1 year.

Additional studies in Europe and the U.S. using the LuX-Valve Plus system are underway, and more clinical results are expected to be released in the future. The Company is continuously advancing the global application of LuX-Valve series system to help more TR patients. As of the latest update, over 600 implantation cases have been completed worldwide with the LuX-Valve series products, and the longest follow-up record has been over 6 years.

Author:管理员

Prev: Trinasolar at the World Economic Forum Japan Summit: Leading the Clean Energy Innovation for the Digital Age

Next: INTERNATIONAL ALLIED HEALTH CONFERENCE 2024: A GLOBAL PLATFORM FOR HEALTHCARE COLLABORATION

Back

Loushixiehou Guesthouse traffic info

Business zone:
Area:qianshanxian
Address: Chazhuang Village,qianshanxian,AnQing,Anhui